Literature DB >> 18372043

Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.

Noriyuki Hirata1, Yoshiki Yanagawa, Takashi Ebihara, Tsukasa Seya, Satoshi Uematsu, Shizuo Akira, Fumie Hayashi, Kazuya Iwabuchi, Kazunori Onoé.   

Abstract

Toll-like receptor (TLR) ligands, i.e. lipopolysaccharide (LPS), induce dendritic cell (DC) production of both inflammatory and anti-inflammatory cytokines including interleukin (IL)-12, tumor necrosis factor (TNF)-alpha, and IL-10. The balance of inflammatory versus anti-inflammatory cytokines appears to be crucial to control immune homeostasis. In the present study, we investigated TLR-mediated regulation of inflammatory versus anti-inflammatory cytokine production using murine bone marrow derived conventional DCs. Standard LPS (sLPS) that contains lipoprotein, a TLR2 ligand, induced vigorous production of both IL-10 and IL-12 p40 by DCs. Highly purified LPS (ultra-pure LPS, upLPS) also induced vigorous production of IL-12 p40, but markedly low IL-10 production. Thus, signal deficiency through TLR2 appeared to result in marked reduction in DC production of IL-10 but not IL-12 p40 upon stimulation with upLPS. To examine this possibility, DCs were stimulated with Pam3CSK4, a synthetic ligand of TLR2, in addition to stimulation with upLPS. It was shown that Pam3CSK4 alone failed to induce IL-10 production. However, Pam3CSK4 synergistically enhanced upLPS-induced DC production of IL-10 but neither IL-12 p40 nor TNF-alpha. Extracellular signal-regulated kinase (ERK)1/2, p38 mitogen-activated protein kinase (MAPK), and c-jun N-terminal kinase (JNK)1/2 in DCs were significantly activated by upLPS stimulation. The upLPS-induced activities of these MAPKs were considerably enhanced by additional stimulation with Pam3CSK4. Blocking either p38 MAPK or JNK1/2 pathway completely inhibited the synergistic enhancement of the IL-10 production by DCs upon upLPS and Pam3CSK4 stimulation. Thus, cooperated stimulation of these MAPKs via TLR4 and TLR2 appeared to induce selective synergy in anti-inflammatory cytokine production by murine conventional DCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372043     DOI: 10.1016/j.molimm.2008.02.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  29 in total

1.  Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation.

Authors:  I Tamayo; J M Irache; C Mansilla; J Ochoa-Repáraz; J J Lasarte; C Gamazo
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

2.  Selective effect of burn injury on splenic CD11c(+) dendritic cells and CD8alpha(+)CD4(-)CD11c(+) dendritic cell subsets.

Authors:  Julie Patenaude; Michele D'Elia; Claudine Hamelin; Jacques Bernier
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

3.  Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.

Authors:  Mario A Moreno-Eutimio; Alejandra Tenorio-Calvo; Rodolfo Pastelin-Palacios; Christian Perez-Shibayama; Cristina Gil-Cruz; Rubén López-Santiago; Isabel Baeza; Marcos Fernández-Mora; Laura Bonifaz; Armando Isibasi; Edmundo Calva; Constantino López-Macías
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

4.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

5.  Toll-like receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury.

Authors:  Philip M Tatum; Carroll M Harmon; Robin G Lorenz; Reed A Dimmitt
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

6.  The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38/JNK signalling.

Authors:  Lucia Fischetti; Ziyun Zhong; Christopher L Pinder; John S Tregoning; Robin J Shattock
Journal:  Cytokine       Date:  2017-08-18       Impact factor: 3.861

7.  Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells.

Authors:  Junfei Jin; Devadoss J Samuvel; Xiaoming Zhang; Yanchun Li; Zhongyang Lu; Maria F Lopes-Virella; Yan Huang
Journal:  Mol Immunol       Date:  2011-10-26       Impact factor: 4.407

8.  Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.

Authors:  R William Depaolo; Fangming Tang; Inyoung Kim; Mei Han; Nadine Levin; Nancy Ciletti; Anning Lin; Debra Anderson; Olaf Schneewind; Bana Jabri
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

9.  Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization.

Authors:  Jun Sik Lee; Sung Jae Shin; Michael T Collins; In Duk Jung; Young-Il Jeong; Chang-Min Lee; Yong Kyoo Shin; Daejin Kim; Yeong-Min Park
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

Review 10.  Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Authors:  Karine Breckpot; David Escors
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2009-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.